LIGHT AND ELECTRON-MICROSCOPIC OBSERVATIONS ON THE CEREBELLUM OF GUINEA-PIGS FOLLOWING LOW-DOSE METHOTREXATE

被引:13
作者
ELBADAWI, MG
FATANI, JA
BAHAKIM, H
ABDALLA, MA
机构
[1] COLL MED, DEPT PEDIAT, RIYADH, SAUDI ARABIA
[2] COLL MED, RES CTR, RIYADH, SAUDI ARABIA
[3] KING SAUD UNIV, KING KHALID UNIV HOSP, RIYADH, SAUDI ARABIA
关键词
D O I
10.1016/0014-4800(90)90045-F
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The neurotoxicity of single and divided low-dose methotrexate (MTX) and the rescue effect of leucovorin (folic acid) were investigated by light and electron microscopic examination of the cerebellum of Guinea pigs. One group of animals received a single weekly intraperitoneal MTX in a dose of 10 mg/kg, a second received a similar dose divided into three equal fractions, and the third group received MTX rescued with an equal dose of leucovorin. The results showed degeneration of Purkinje cells indicated by shrinkage and distortion of perikarya, dissolution of mitochondrial cristae, and nuclear and nucleolar changes in all groups which received MTX. There was also astrocytic proliferation and perivascular edema. Lesser changes were found in the group which was rescued with leucovorin. The degenerative changes in the cerebellum particularly those of the Purkinje cells explain the neurological signs reported in cancer patients treated with MTX. © 1990.
引用
收藏
页码:211 / 222
页数:12
相关论文
共 37 条
[1]   TRANSIENT CEREBRAL-DYSFUNCTION FOLLOWING CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA [J].
ALLEN, JC ;
ROSEN, G .
ANNALS OF NEUROLOGY, 1978, 3 (05) :441-444
[2]   NEUROTOXICITY AND ELEVATED CEREBROSPINAL-FLUID METHOTREXATE CONCENTRATION IN MENINGEAL LEUKEMIA [J].
BLEYER, WA ;
DRAKE, JC ;
CHABNER, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (15) :770-773
[3]  
CAPIZZI RL, 1970, CANCER RES, V30, P1782
[4]   PROGRESSION OF METHOTREXATE-INDUCED LEUKOENCEPHALOPATHY IN CHILDREN WITH LEUKEMIA [J].
CHIEN, LT ;
AUR, RJA ;
VERZOSA, MS ;
COBURN, TP ;
GOFF, JR ;
HUSTU, HO ;
PRICE, RA ;
SEIFERT, MJ ;
SIMONE, JV .
MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (02) :133-141
[5]  
DASKAL Y, 1980, CISPLATIN CURRENT ST, P249
[6]  
DJERASSI I, 1967, CANCER, V20, P233, DOI 10.1002/1097-0142(1967)20:2<233::AID-CNCR2820200209>3.0.CO
[7]  
2-8
[8]  
DJERASSI I, 1977, CANCER TREAT REP, V61, P751
[9]   HISTOLOGICAL-CHANGES FOLLOWING HIGH-DOSE METHOTREXATE AND CISPLATINUM ADMINISTRATION AND THE INFLUENCE OF DOSAGE SCHEDULING [J].
ELBADAWI, MG ;
AMER, MH ;
DAHABA, NM ;
FATANI, JA ;
SABAH, DM ;
MUSTAFA, FA .
CHEMOTHERAPY, 1987, 33 (04) :278-286
[10]  
ELBADAWI MG, 1987, ANAT ANZEIGER, V164, P47